In vitro studies have demonstrated that Bifidobacterium bifidus are protective against TNFα-induced loss of trans-epithelial electro-resistance [18], of relevance in IBD as anti-TNFα medication is an established therapy in IBD. Here, TNF is linked to irritable bowel syndrome.